Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:153282.
doi: 10.1155/2011/153282. Epub 2011 Jun 23.

CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients

Affiliations

CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients

Rosalia D'Angelo et al. Mult Scler Int. 2011.

Abstract

Multiple sclerosis (MS) disease is carried through inflammatory and degenerative stages. Based on clinical feaures, it can be subdivided into three groups: relapsing-remitting MS, secondary progressive MS, and primary progressive MS. Multiple sclerosis has a multifactorial etiology with an interplay of genetic predisposition, environmental factors, and autoimmune inflammatory mechanism in which play a key role CC-chemokines and its receptors. In this paper, we studied the frequency of CCR5 gene Δ32 allele in a cohort of Sicilian RR-MS patients comparing with general Sicilian population. Also, we evaluate the association between this commonly polymorphism and disability development and age of disease onset in the same cohort. Our results show that presence of CCR5Δ32 is significantly associated with expanded disability status scale score (EDSS) but not with age of disease onset.

PubMed Disclaimer

References

    1. Bosnjak-Pasić M, Vidrih B, Miskov S, Demarin V. Treatment of multiple sclerosis. Acta Clinica Croatica. 2009;48(3):349–353. - PubMed
    1. Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359(9313):1221–1231. - PubMed
    1. Hansen T, Skytthe A, Stenager E, Petersen HC, Brønnum-Hansen H, Kyvik KO. Concordance for multiple sclerosis in Danish twins: an update of a nationwide study. Multiple Sclerosis. 2005;11(5):504–510. - PubMed
    1. Willer CJ, Dyment DA, Risch NJ, et al. Twin concordance and sibling recurrence rates in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(22):12877–12882. - PMC - PubMed
    1. Yan J, Greer JM. NF-κB, a potential therapeutic target for the treatment of multiple sclerosis. CNS and Neurological Disorders. 2008;7(6):536–557. - PubMed

LinkOut - more resources